Загрузка...
Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders
Childhood neurotransmitter disorders are increasingly recognised as an expanding group of inherited neurometabolic syndromes. They are caused by disturbance in synthesis, metabolism, and homeostasis of the monoamine neurotransmitters, including the catecholamines (dopamine, norepinephrine, and epine...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4102824/ https://ncbi.nlm.nih.gov/pubmed/25011953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-014-0079-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|